By Shaoyu Chang, MD, MPH, Senior Research Manager, LSN
At the intersection between life science and computer science, healthcare IT continues to attract strong interests from both camps. VC funds, big pharmas, and tech corporates are all actively seeking the next big thing in HCIT that would transform healthcare fundamentally.
Some of the biggest players in HCIT investment will speak at RESI San Francisco to share their expertise and advice with entrepreneurs. Moderated by Anne DeGheest, Founder of HealthTech Capital, the panel will feature:
- Janhvi Patel, Business Development Manager, IBM Watson Ecosystem
- Joel Krikston, Managing Director, Merck Global Health Innovation Fund
- Lucian Iancovici, Investment Manager, Qualcomm Life Fund
- Rich Simoni, Partner, Asset Management Ventures
This panel will provide fundraising entrepreneurs with an inside peak into the strategy of these HCIT investors – How do you make your company stand out in this crowded marketplace? What do investors see as the most high-potential fields of innovation in healthcare IT? How do you demonstrate to an investor that your product has the potential to succeed?
If you’re interested in listening to this panel live at RESI, you can register for RESI San Francisco now. RESI provides a great opportunity to expand your network in the life sciences and to get a better understanding of fundraising process, and January 12th will be our largest gathering yet.
Next Phase Newsletter 
Leave a comment